ProCE Banner Series

A Treatment Option for Patients with ER+/HER2-  ESR1-mutated mBC Following  Progression on Initial ET +/- a CDK4/6i

Join us to gain insights on metastatic breast cancer second line options.

Key Takeaways:

  • Understanding testing and treatment for ESR1-mutated mBC

All Events

A Treatment Option for Patients with ER+/HER2-ESR1-mutated mBC Following Progression on Initial ET +/- a CDK4/6i

Past Events

December

20

2024

11:00 AM - 11:30 AM Eastern Time (ET)

Virtual